Correction to: Peeling Skin Syndrome Type 1: Dupilumab Reduces IgE, But Not Skin Anomalies

Affiliations

¹ Dermatology Department, Reference Center for Rare Skin Diseases, Paul Sabatier University, Larrey Hospital, 24 Chemin de Pouvourville, 31059 Cedex 09, Toulouse, France.
² Infinity, Inserm - CNRS - UPS, Toulouse, France.
³ Pediatric Pneumology and Allergology Center, Children's Hospital, 330 avenue de Grande‑Bretagne, 31059 Cedex 09, Toulouse, France.
⁴ Federal Institute of Biology, CHU de Toulouse, Toulouse, France.
⁵ UMR 1056 INSERM, Hôpital Purpan, Toulouse, France.
⁶ Dermatology Department, Reference Center for Rare Skin Diseases, Paul Sabatier University, Larrey Hospital, 24 Chemin de Pouvourville, 31059 Cedex 09, Toulouse, France. mazereeuw-hautier.j@chu-toulouse.fr.

Published Erratum

Alexis Barranca et al. J Clin Immunol. 2022 Nov.

. 2022 Nov;42(8):1810.

doi: 10.1007/s10875-022-01309-2.

¹ Dermatology Department, Reference Center for Rare Skin Diseases, Paul Sabatier University, Larrey Hospital, 24 Chemin de Pouvourville, 31059 Cedex 09, Toulouse, France.
² Infinity, Inserm - CNRS - UPS, Toulouse, France.
³ Pediatric Pneumology and Allergology Center, Children's Hospital, 330 avenue de Grande‑Bretagne, 31059 Cedex 09, Toulouse, France.
⁴ Federal Institute of Biology, CHU de Toulouse, Toulouse, France.
⁵ UMR 1056 INSERM, Hôpital Purpan, Toulouse, France.
⁶ Dermatology Department, Reference Center for Rare Skin Diseases, Paul Sabatier University, Larrey Hospital, 24 Chemin de Pouvourville, 31059 Cedex 09, Toulouse, France. mazereeuw-hautier.j@chu-toulouse.fr.

No abstract available

Erratum for

Peeling Skin Syndrome Type 1: Dupilumab Reduces IgE, But Not Skin Anomalies.
Alexis B, Nathalie J, Audrey MB, Pol-André A, Juliette MH. Alexis B, et al. J Clin Immunol. 2022 May;42(4):873-875. doi: 10.1007/s10875-021-01194-1. Epub 2022 Feb 23. J Clin Immunol. 2022. PMID: 35194710 No abstract available.